摘要 |
The present invention relates to an in vitro method for the prognosis or prediction of the response to treatment with anti-psychotic drugs in subjects who have suffered first episode psychosis (FEP), and specifically to the use of the expression value, in a biological sample isolated from said subjects, of the ratio formed by two of the isoforms – active isoform and truncated isoform – of the receptor (TrKB) of the nerve growth factor BDNF, named TrKB-FL and TrkB-T, respectively. The present invention also describes kits and uses of same to implement the method of the invention. |
申请人 |
Centro de Investigación Biomédica en Red;Universidad del País Vasco / Euskal Herriko Unibertsitatea;Administración General de la Comunidad Autónoma de Euskadi;Hospital Clinic;Universidad Complutense de Madrid;Universitat de Barcelona;Universidad de Cádiz;Universidad de Oviedo;Universidad de Zaragoza |
发明人 |
Martínez Cengotitabengoa, Mónica;González-Pinto, Ana María;Alberich Mesa, Susana;Leza Cerro, Juan Carlos;Macdowell Mata, Karina;Parellada Redondo, María José;Rodríguez Jiménez, Roberto;Bernardo Arroyo, Miguel;Sáiz Martínez, Pilar Alejandra;Micó Segura, Juan Antonio;Lobo Satué, Antonio;Matute Almau, Carlos |